Pooyan Afzali Harsini¹*, Ali Khani Jeihooni², Gholamreza Imani³ and Saeed hamzehie³

¹Nutrition Research Center, Department of Public Health, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran
²MD, Department of Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
³MD, Internal Medicine Specialist, Department of Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

*Corresponding Author: Pooyan Afzali Harsini, Nutrition Research Center, Department of Public Health, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran.

Received: October 17, 2023; Published: November 16, 2023

Abstract

Coronaviruses (COVID-19) are encapsulated viruses with a self, positive-sense RNA genome that are proven to cause respiratory disease in humans. Coronaviruses (COVID-19) are a type of virus that infects the respiratory tract [1]. In most immunocompetent individuals, infection with human COVID-19results in a moderate upper respiratory infection in the majority of cases. The outbreaks of severe acute respiratory syndrome (SARS) in Guangdong province, China, in 2003 and Middle East respiratory syndrome (MERS) in Middle Eastern countries a decade later were caused by two highly virulent COVID-19.

References

1. Sheahan TP., et al. “Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV”. Nature communications 1 (2020): 1-14.
2. Zhong N., et al. “Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003”. The Lancet 9393 (2003): 1353-1358.
3. Park S-Y., et al. “High prevalence of asthma in elderly women: findings from a Korean national health database and adult asthma cohort”. Allergy, Asthma and Immunology Research4 (2014): 387-396.
4. Sun P., et al. “Clinical characteristics of hospitalized patients with SARS‐CoV‐2 infection: a single arm meta‐analysis”. Journal of Medical Virology6 (2020): 612-617.
5. Coronavirus Cases.
6. Alhazzani W., et al. “Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)”. Intensive care Medicine (2020): 1-34.
7. Wu Z and McGoogan JM. “Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention”. JAMA 13 (2020): 1239-1242.
8. Iacobellis G., et al. “Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes”. Diabetes Research and Clinical Practice 164 (2020): 108185.
9. Bornstein SR., et al. “Practical recommendations for the management of diabetes in patients with COVID-19”. The Lancet Diabetes and Endocrinology6 (2020): 546-550.
10. Elamari S., et al. “Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2”. Pan African Medical Journal1 (2020).
11. Ceriello A. “Hyperglycemia and COVID-19: What was known and what is really new?” Diabetes Research and Clinical Practice 167 (2020): 108383.
12. Nassar M., et al. “Diabetes mellitus and COVID-19”. Diabetes and Metabolic Syndrome: Clinical Research and Reviews6 (2021): 102268.
13. Alessi J., et al. “Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes”. Diabetology and Metabolic Syndrome 12 (2020): 1-11.
14. Song Z., et al. “From SARS to MERS, thrusting coronaviruses into the spotlight”. Viruses1 (2019): 59.
15. Yang J., et al. “Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS”. Diabetic Medicine6 (2006): 623-628.
16. Woolcott OO and Castilla-Bancayán JP. “The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico”. Scientific Reports1 (2021): 8386.
17. McMichael TM., et al. “COVID-19 in a long-term care facility-King County, Washington, February 27-March 9, 2020”. Morbidity and Mortality Weekly Report12 (2020): 339.
18. Elflein J. “COVID-19 deaths reported in the U.S. as of December 1, 2021, by age 2021 (2021).
19. De Vita N., et al. “Predictors of intubation in COVID-19 patients treated with out-of-ICU continuous positive airway pressure”. Pulmonology (2021).
20. Cariou B., et al. “Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study”. Diabetologia8 (2020): 1500-1515.
21. Rezaei N., et al. “COVID-19 in patients with diabetes: factors associated with worse outcomes”. Journal of Diabetes and Metabolic Disorders (2021): 1-10.
22. Kumar A., et al. “Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis”. Diabetes and Metabolic Syndrome: Clinical Research and Reviews4 (2020): 535-545.
23. Ho FK., et al. “Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants”. PLoS One11 (2020): e0241824.
24. Tamura RE., et al. “Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies”. Diabetes and Metabolic Syndrome1 (2021): 76.
25. Corona G., et al. “Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis”. Reviews in Endocrine and Metabolic Disorders 2 (2021): 275-96.
26. Poissy J., et al. “Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence”. Circulation2 (2020): 184-186.
27. Rodriguez-Morales AJ., et al. “Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis”. Travel Medicine and Infectious Disease 34 (2020): 101623.
28. Lim S., et al. “COVID-19 and diabetes mellitus: from pathophysiology to clinical management”. Nature Reviews Endocrinology1 (2021): 11-30.
29. Petrie JR., et al. “Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms”. Canadian Journal of Cardiology5 (2018): 575-584.
30. Giacco F and Brownlee M. “Oxidative stress and diabetic complications”. Circulation Research9 (2010): 1058-1070.
31. Šestan M., et al. “Virus-induced interferon-γ causes insulin resistance in skeletal muscle and derails glycemic control in obesity”. Immunity1 (2018): 164-177. e6.
32. Chen J., et al. “The impact of COVID-19 on blood glucose: a systematic review and meta-analysis”. Frontiers in Endocrinology 11 (2020): 574541.

Citation

Citation: Pooyan Afzali Harsini., et al. “COVID-19 and Diabetes Mellitus Patients".Acta Scientific Nutritional Health 7.12 (2023): 10-13.

Copyright

Copyright: © 2023 Pooyan Afzali Harsini., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.